A couple weeks ago, I posted about a new scientific paper looking at how an increased understanding of psychedelic drugs may lead to new anti-depressants. Over at Science Blogs, neuroscientist Moheb Costandi responds in a fascinating essay on "The Secret History of Psychedelic Psychiatry." From the article:
LSD therapy peaked in the 1950s, during which time it was even used to treat Hollywood film stars, including luminaries such as Cary Grant (at left, dropping acid). By then, two forms of therapy had emerged. Psychedelic ("mind-manifesting") therapy was practised mostly in North America and involved intensive psychotherapy followed by a single megadose of LSD. It was thought that the transcendental experiences induced by such large doses, as well as heightened self-awareness, would enable the patient to reflect on their condition with greater clarity. Psycholytic ("mind-loosening") therapy, on the other hand, was practised mostly in Europe, and involved regular low to moderate doses of the drug in conjunction with psychoanalysis, in order to release long-lost memories and reveal the unconscious mind.